700872-93-1

Basic information

• Product Name: 7-(3,4-Dichlorophenyl)-4-(2-pyridin-2-yl-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinoline
• Synonyms: 7-(3,4-Dichlorophenyl)-4-(2-pyridin-2-yl-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinoline
• CAS NO: 700872-93-1
• Molecular Weight: 457.362
• Mol File: 700872-93-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 7-(3,4-Dichlorophenyl)-4-(2-pyridin-2-yl-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinoline(CAS DataBase Reference)
• NIST Chemistry Reference: 7-(3,4-Dichlorophenyl)-4-(2-pyridin-2-yl-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinoline(700872-93-1)
• EPA Substance Registry System: 7-(3,4-Dichlorophenyl)-4-(2-pyridin-2-yl-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinoline(700872-93-1)

Safety Data

• Hazardous Substances Data: 700872-93-1(Hazardous Substances Data)

Upstream product

• 151169-75-4 3,4-dichlophenylboronic acid 
• 476477-23-3 7-Bromo-4-[(2-pyridin-2-yl)-5, 6-dihydro-4H-pyrrolo [1, 2-b] pyrazol-3-yl] quinoline 

Relevant articles and documents

MIXED LINEAGE KINASE MODULATORS

The present invention provides a compound of the formula: (Formula I); or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising an effective amount of a compound of Formula I in combination with a suitable carrier, diluent, or excipient, and methods for treating physiological disorders, particularly congestive heart disease, comprising administering to a patient in thereof an effective amount of a compound of Formula I.